Book[edited by] David J. Dabbs.
Contents:
1. Normal breast and developmental disorders
2. Reactive and inflammatory conditions of the breast
3. Infections of the breast
4. Epidemiology of breast cancer and pathology of heritable breast cancer
5. Patient safety in breast pathology
6. Gross examination of breast pathology
7. Sentinel lymph node biopsy
8. Breast imaging modalities for pathologists
9. Predictive and prognostic marker testing in breast pathology: immunophenotypic subclasses of disease
10. Molecular-based testing in breast disease for therapeutic decisions
11. Diagnostic immunohistology of the breast
12. Fibroepithelial lesions
13. Papilloma and papillary lesions
14. Adenosis and microglandular adenosis
15. Nipple adenoma (florid papillomatosis of the nipple)
16. Radial scar
17. Myoepithelial lesions of the breast
18. Fibrocystic change and usual epithelial hyperplasia of ductal type
19. Columnar cell alterations, flat epithelial atypia, and atypical ductal epithelial hyperplasia
20. Molecular classification of breast carcinoma
21. Lobular neoplasia and invasive lobular carcinoma
22. Ductal carcinoma in situ
23. Invasive ductal carcinoma of no special type and histologic grade
24. Triple-negative and basal-like carcinoma
25. Metaplastic breast carcinoma
26. Apocrine carcinoma of the breast
27. Paget disease of the breast
28. Pathology of neoadjuvant therapeutic response of breast carcinoma
29. Special types of invasive breast: tubular carcinoma, mucinous carcinoma, cribriform carcinoma, micropapillary carcinoma, carcinoma with medullary features
30. Rare breast carcinomas: adenoid cystic carcinoma, neuroendocrine carcinoma, secretory carcinoma, carcinoma with osteoclast-like giant cells, lipid-rich carcinoma, and glycogen-rich clear cell carcinoma
31. Mesenchymal neoplasms of the breast
32. Neoplasia of the male breast
33. Breast tumors in children and adolescents
34. Tumors of the mammary skin
35. Hematopoietic tumors of the breast
36. Metastatic tumors in the breast
37. Next-generation DNA sequencing and the management of patients with clinically advanced breast cancer.